Chenliang Zhou

InstitutionShanghai Zerun Biotechnology Co.
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in April 2021
    All Publications
    Bar chart showing 17 publications over 6 distinct years, with a maximum of 6 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Xiao Y, Wu D, Shi X, Liu S, Hu X, Zhou C, Tian X, Liu H, Long H, Li Z, Wang J, Tan T, Xu Y, Chen B, Liu T, Zhang H, Zheng S, Hu S, Song J, Tang J, Song J, Cheng Z, Xu W, Shen Y, Yu W, Xu Y, Li J, Zhou J, Wang F, Chen M. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence. 2021 12; 12(1):1199-1208. PMID: 33870852.
      Citations:    Fields:    Translation:Humans
    2. Liu Y, Xie W, Meng Y, Sun L, Yan J, Dong W, Zhou C, Yu Z. The clinical course of critically ill COVID-19 patients receiving invasive mechanical ventilation with subsequent terminal weaning: Primary data from 11 cases. Medicine (Baltimore). 2021 Apr 23; 100(16):e25619. PMID: 33879732.
      Citations:    Fields:    Translation:Humans
    3. Wang L, Cheng X, Dong Q, Zhou C, Wang Y, Song B, Li W, Wang M, Qin R, Long Q, Liu J, Li J, Li D, Li G, Ba Y. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients. BMC Infect Dis. 2021 Apr 20; 21(1):371. PMID: 33879073.
      Citations: 1     Fields:    Translation:Humans
    4. Dai X, Zhang Y, Yu L, Jiang YA, Chen L, Chen Y, Li M, Gao C, Shang J, Xiang S, Li Y, Li J, Zhou C, Zhou X, Chen N, Liu Y, Liu J, Zhang Y, Chen X, Zhu D, Gao H, Tang L, Zhu M, Li L. Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients. Artif Organs. 2021 Jul; 45(7):762-769. PMID: 33326621.
      Citations: 3     Fields:    Translation:Humans
    5. Xu X, Jiang W, Chen L, Xu Z, Zhang Q, Zhu M, Ye P, Li H, Yu L, Zhou X, Zhou C, Chen X, Zheng X, Xu K, Cai H, Zheng S, Jiang W, Wu X, Li D, Chen L, Luo Q, Wang Y, Qu J, Li Y, Zheng W, Jiang Y, Tang L, Xiang C, Li L. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med. 2021 02; 11(2):e297. PMID: 33634996.
      Citations: 12     Translation:HumansCellsCTClinical Trials
    6. Liang T, Qiu J, Niu X, Ma Q, Zhou C, Chen P, Zhang Q, Chen M, Yang Z, Liu S, Li L. 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor. Front Pharmacol. 2020; 11:603830. PMID: 33519467.
      Citations: 1     
    7. Zhou C, Zhang T, Ren H, Sun S, Yu X, Sheng J, Shi Y, Zhao H. Impact of age on duration of viral RNA shedding in patients with COVID-19. Aging (Albany NY). 2020 11 20; 12(22):22399-22404. PMID: 33223506.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    8. Zhang C, Zhou C, Shi L, Liu G. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hum Vaccin Immunother. 2020 Oct 02; 16(10):2366-2369. PMID: 32961082.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    9. Tang L, Jiang Y, Zhu M, Chen L, Zhou X, Zhou C, Ye P, Chen X, Wang B, Xu Z, Zhang Q, Xu X, Gao H, Wu X, Li D, Jiang W, Qu J, Xiang C, Li L. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19. Front Med. 2020 Oct; 14(5):664-673. PMID: 32761491.
      Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
    10. Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12; 21(1):520. PMID: 32532356.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    11. Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, Bi J, Zhan G, Xu X, Wang L, Zhou Q, Zhou C, Pan Y, Liu S, Zhang H, Yang J, Zhu B, Hu Y, Hashimoto K, Jia Y, Wang H, Wang R, Liu C, Yang C. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun. 2020 08; 88:916-919. PMID: 32169498.
      Citations: 275     Fields:    Translation:HumansCellsPHPublic Health
    Zhou's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (98)
    Explore
    _
    Co-Authors (163)
    Explore
    _
    Similar People (60)
    Explore
    _